×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [37]
内容类型
期刊论文 [34]
会议论文 [3]
发表日期
2019 [9]
2018 [13]
2017 [2]
2016 [2]
2015 [5]
2014 [3]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共37条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
A validated ultra-HPLC-MS/MS method for determination of honokiol in human plasma and its application to a clinical pharmacokinetic study
期刊论文
2019, 卷号: 11, 期号: 11, 页码: 1085-1098
作者:
Zhuang, Quankun
;
Pan, Ruili
;
Liu, Xuemei
;
Xu, Wen
;
Wang, Hanping
收藏
  |  
浏览/下载:40/0
  |  
提交时间:2020/01/03
first in-human
honokiol
honokiol liposome injection
human plasma
pharmacokinetics
UPLC-MS
MS
Successful treatment with osimertinib and its subsequent resistance mechanism in a patient with non-small-cell lung cancer harboring acquired EGFR T790M mutation after recovery from AC0010-induced interstitial lung disease
期刊论文
2019, 卷号: 12, 页码: 5545-5549
作者:
Wang, Hanping
;
Zhang, Li
;
Shi, Xiaohua
;
Zhang, Xiaotong
;
Si, Xiaoyan
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/03
osimertinib
AC0010
interstitial lung disease
resistance mechanism
transformation
large-cell neuroendocrine carcinoma
The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases
期刊论文
2019, 卷号: 10, 期号: 9, 页码: 1985-1990
作者:
Wang, Chunyu
;
Lu, Xiaotong
;
Zhou, Zongmei
;
Wang, Jingbo
;
Hui, Zhouguang
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2020/01/03
non-small cell lung cancer
EGFR mutation
brain metastases
radiation
tyrosine kinase inhibitors
Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis
期刊论文
2019, 卷号: 14, 期号: 4
作者:
Li, Shuang
;
Cao, Yuze
;
Li, Lei
;
Zhang, Huixue
;
Lu, Xiaoyu
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study
期刊论文
2019, 卷号: 14, 期号: 1, 页码: 106
作者:
Wang, Daquan
;
Bi, Nan
;
Zhang, Tao
;
Zhou, Zongmei
;
Xiao, Zefen
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2020/01/03
Non-small cell lung cancer
Simultaneous integrated boost
Intensity-modulated radiotherapy
Survival
Toxicity
LncRNA ENST00000602558.1 regulates ABCG1 expression and cholesterol efflux from vascular smooth muscle cells through a p65-dependent pathway
期刊论文
2019, 卷号: 285, 页码: 31-39
作者:
Cai, Can
;
Zhu, Huijuan
;
Ning, Xiaotong
;
Li, Lin
;
Yang, Bin
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2020/01/03
Atherosclerosis
ENST00000602558.1
VSMCs
ABCG1
Cholesterol efflux
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303
期刊论文
2019, 卷号: 10, 期号: 3, 页码: 551-556
作者:
Si, Xiaoyan
;
Zhang, Li
;
Wang, Hanping
;
Zhang, Xiaotong
;
Wang, Mengzhao
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/01/03
Adverse event
anlotinib
multi-target tyrosine kinase inhibitor
non-small cell lung cancer
Global pathway view analysis of microRNA clusters in myasthenia gravis
期刊论文
2019, 卷号: 19, 期号: 3, 页码: 2350-2360
作者:
Bo, Chunrui
;
Wang, Jianjian
;
Zhang, Huixue
;
Cao, Yuze
;
Lu, Xiaoyu
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/03
myasthenia gravis
pathway analysis
microRNA clusters
The long noncoding RNA MALAT-1 functions as a competing endogenous RNA to regulate MSL2 expression by sponging miR-338-3p in myasthenia gravis
期刊论文
2019, 卷号: 120, 期号: 4, 页码: 5542-5550
作者:
Kong, Xiaotong
;
Wang, Jianjian
;
Cao, Yuze
;
Zhang, Huixue
;
Lu, Xiaoyu
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2020/01/03
cell
competing endogenous RNA (ceRNA)
immune disease
metastasis-associated lung adenocarcinoma transcript 1 (MALAT-1)
myasthenia gravis (MG)
Re-biopsy status among Chinese non-small-cell lung cancer patients who progressed after icotinib therapy
期刊论文
2018, 卷号: 11, 页码: 7513-7519
作者:
Wang, Hanping
;
Zhang, Li
;
Si, Xiaoyan
;
Zhang, Xiaotong
;
Wang, Mengzhao
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
re-biopsy
T790M mutation
resistant mechanism
EGFR-TKI
icotinib
non-small-cell lung cancer
©版权所有 ©2017 CSpace - Powered by
CSpace